AIDS researchers have for the first time demonstrated that human blood stem cells can be engineered into cells that can target and kill HIV-infected cells — a process that potentially could be used against a range of chronic viral diseases. The study, published today in PLoS ONE, demonstrates that human stem cells can be engineered into the equivalent of a genetic vaccine.
By Taking CD8 cytotoxic T lymphocytes — the "killer" T cells that help fight infection — from an HIV-infected individual, the researchers identified the molecule known as the T-cell receptor, which guides the T cell in recognizing and killing HIV-infected cells.
These cells, while able to destroy HIV-infected cells, do not exist in enough quantities to clear the virus from the body. So the researchers cloned the receptor and genetically engineered human blood stem cells, then placed the stem cells into human thymus tissue that had been implanted in mice, allowing them to study the reaction in a living organism.
The engineered stem cells developed into a large population of mature, multifunctional HIV-specific CD8 cells that could specifically target cells containing HIV proteins. The researchers also found that HIV-specific T-cell receptors have to be matched to an individual in much the same way that an organ is matched to a transplant patient.
"We have demonstrated in this proof-of-principle study that this type of approach can be used to engineer the human immune system, particularly the T-cell response, to specifically target HIV-infected cells," said lead investigator Scott G. Kitchen, assistant professor of medicine in the division of hematology and oncology at UCLA.
"These studies lay the foundation for further therapeutic development that involves restoring damaged or defective immune responses toward a variety of viruses that cause chronic disease, or even different types of tumors."
The next step is to test this strategy in a more advanced model to determine if it would work in the human body, said co-author Jerome A. Zack, UCLA professor of medicine in the division of hematology and oncology and associate director of the UCLA AIDS Institute. The researchers also hope to expand the range of viruses against which this approach could be used.
Citation: Kitchen SG, Bennett M, Galić Z, Kim J, Xu Q, et al., 'Engineering Antigen-Specific T Cells from Genetically Modified Human Hematopoietic Stem Cells in Immunodeficient Mice', PLoS ONE 2009, 4(12): e8208. doi:10.1371/journal.pone.0008208
- PHYSICAL SCIENCES
- EARTH SCIENCES
- LIFE SCIENCES
- SOCIAL SCIENCES
Subscribe to the newsletter
Stay in touch with the scientific world!
Know Science And Want To Write?
- Is That A Real Patient Or A Junkie? Now There's An App For That
- Inhibiting Inflammatory Enzyme After Heart Attack Does Not Reduce Risk Of Subsequent Event
- Antarctic Sea Level Rising Faster Than Elsewhere
- How The Higgs Became The Target Of Run 2 At The Tevatron
- How Neuroscience Is Being Used To Spread Quackery In Business And Education
- MOOCs: Learning About Online Learning, One Click At A Time
- You Are Ready To Eat Insects If You Have These Characteristics
- "No astronauts have died. Maybe astronauts are smarter about it than geckos? They may have asked..."
- "peaches4me,In assuming 32, you are making the same mistake to the one you mention in your post..."
- "I am not talking about the inner product in your Hilbert space! The issue I'm focusing on..."
- "Minor quibble: It was the Library of Alexandria, not Alexandra. The name derives from the conquest..."
- "10 years is not that long. ..."
- CMOS biomimicry: Biomimetic photodetector 'sees' in color
- Experts defend operational earthquake forecasting, counter critiques
- Likely near-simultaneous earthquakes complicate seismic hazard planning for Italy
- Low-carb vs. low-fat diets
- Organic vs. paid advertising? Inside the mind of an online browser